Back

Western drugmakers seek to preserve China deals under 2025 investment law

Verifying
  • Western pharmaceutical companies are urging the administration to preserve deals with Chinese companies.
  • 2025 law restricts U.S. investment in Chinese technology.
  • Pharmaceutical industry group represents Pfizer, Merck and Eli Lilly in lobbying Treasury.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.